Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      8 trials found for Lymphoma

      All(8)
      Recruiting(7)
      Not yet recruiting(1)
      Recruiting
      NCT06120504
      A Safety Study of SGN-35T in Adults With Advanced Cancers

      Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin

      Male or Female
      18+ years
      2study location(s)
      Recruiting
      NCT05896774
      A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China

      Non-Hodgkin Lymphoma, Multiple Myeloma

      Male or Female
      18+ years
      6study location(s)
      Recruiting
      NCT03460977
      PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

      Castration Resistant Prostate Cancer (CRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)

      Male or Female
      18+ years
      128study location(s)
      Recruiting
      NCT05896163
      A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.

      Diffuse Large B-Cell Lymphoma

      Male or Female
      18+ years
      24study location(s)
      Recruiting
      NCT05626322
      Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

      Diffuse Large B-Cell Lymphoma

      Male or Female
      18+ years
      44study location(s)
      Recruiting
      NCT05160922
      Crizotinib Continuation Clinical Study

      NSCLC, ALCL, IMT

      Male or Female
      1 - 99 years
      14study location(s)
      Recruiting
      NCT05144997
      Lorlatinib Continuation Study

      Non-Small-Cell Lung Cancer, NSCLC

      Male or Female
      18+ years
      18study location(s)
      May 31, 2024 - Planned start date (Not yet recruiting)
      NCT06254495
      A Safety Study of SGN-35C in Adults With Advanced Cancers

      Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

      Male or Female
      18+ years
      1study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(8)
      Recruiting(7)
      Not yet recruiting(1)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.